Media Bottle with Multiport Closure System Presented at INTERPHEX 2019
The Kimble GLS 80 Media Bottle and Multiport Cap System from DWK Life Sciences, showcased at INTERPHEX 2019 in New York City, is capable of performing a multitude of laboratory applications.
DWK Life Sciences, a manufacturer and supplier of precision labware, showcased its new Kimble GLS 80 Media Bottle and Multiport Cap System at INTERPHEX on April 2–4, 2019 at the Javits Center in New York City.
The bottle and cap system are suited to help scientists accommodate a range of sample sizes from 250 mL to 20 L, and can be used for biological and chemical reactions, plant cell culture, photobiological studies, and sample collection and storage. The wide neck simplifies transfer of samples in various form, including powders, pastes, granules, and liquids. Spoons, spatulas, tweezers, and large funnels are easily manipulated through the opening, according to the company.
The four-port multiport cap system provides a choice of five port inserts designed to fit different size tubing. Constructed of polypropylene and polytetrafluorethylene, the cap components are autoclavable. When combined with the multiport cap, the bottle can be used in applications in the energy, materials science, pharmaceutical, and biotechnology research fields. Resistant to acids, corrosive chemicals and thermal shock, the bottles withstand temperatures as high as 500 ËC.
Manufactured from 33-expansion low-extractable borosilicate glass in conformance with the USP Type I standard for neutral glass, the bottle is available in clear glass or with an amber-coated exterior for light-sensitive materials, or with KimCote safety coating for protection in the event of damage. Bottles are fitted with a matching pouring ring for drip-free pouring. Easy-to-read volume graduations and a white marking patch allow for clear identification of bottle contents.
Source: DWK Life Sciences
FDA Approves First Treatment for Rare Lipid Storage Disease Cerebrotendinous Xanthomatosis
February 24th 2025Cerebrotendinous xanthomatosis, or CTX, is a metabolic disorder caused by a gene mutation that results in a deficiency of an important enzyme in the ability of the human body to break down fats.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment
February 18th 2025Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.
